Literature DB >> 16639859

Motivational interviewing with adolescents and young adults for drug-related problems.

Jerry L Grenard1, Susan L Ames, Mary Ann Pentz, Steve Sussman.   

Abstract

This article reviews studies of brief motivational interviewing (MI) interventions applied to adolescents (ages 13 to 18 years) and young adults (ages 19 to 25 years) using alcohol or other psychoactive substances. An overview of the principles of MI is provided followed by a review of 17 clinical studies reported in the literature. This review revealed mixed findings for the efficacy of brief MI among these populations. However, in 29% of the studies (5 of 17), there was a clear advantage of the brief MI demonstrated compared to standard care or other programming. Components common to successful brief MI interventions included one-on-one sessions and feedback on substance use compared to norms. Interviewer empathy has been shown to be a key component in studies with adults, but this was not measured in a standardized manner across the current studies. The studies reviewed here indicate that brief MI might be effective among these populations, but the key components necessary for successful MI interventions have not been fully identified.

Entities:  

Mesh:

Year:  2006        PMID: 16639859     DOI: 10.1515/ijamh.2006.18.1.53

Source DB:  PubMed          Journal:  Int J Adolesc Med Health        ISSN: 0334-0139


  24 in total

1.  ENROLLING AND ENGAGING HIGH-RISK YOUTH AND FAMILIES IN COMMUNITY-BASED, BRIEF INTERVENTION SERVICES.

Authors:  Richard Dembo; Laura Gulledge; Rhissa Briones Robinson; Ken C Winters
Journal:  J Child Adolesc Subst Abuse       Date:  2011-09

2.  Brief intervention for drug-abusing adolescents in a school setting: outcomes and mediating factors.

Authors:  Ken C Winters; Tamara Fahnhorst; Andria Botzet; Susanne Lee; Britani Lalone
Journal:  J Subst Abuse Treat       Date:  2011-10-14

3.  Inside the physician's black bag: critical ingredients of brief alcohol interventions.

Authors:  Paul Grossberg; Abigail Halperin; Sara Mackenzie; Mary Gisslow; David Brown; Michael Fleming
Journal:  Subst Abus       Date:  2010-10       Impact factor: 3.716

4.  Brief intervention for substance use among at-risk adolescents: a pilot study.

Authors:  Jerry L Grenard; Susan L Ames; Reinout W Wiers; Carolien Thush; Alan W Stacy; Steve Sussman
Journal:  J Adolesc Health       Date:  2006-10-27       Impact factor: 5.012

5.  [Motivational interviews: what are their effectiveness in prevalent primary care problems?].

Authors:  Solange Rivera Mercado; M Francisca Villouta Cassinelli; Andrés Ilabaca Grez
Journal:  Aten Primaria       Date:  2008-05       Impact factor: 1.137

6.  One-year outcomes and mediators of a brief intervention for drug abusing adolescents.

Authors:  Ken C Winters; Susanne Lee; Andria Botzet; Tamara Fahnhorst; Ali Nicholson
Journal:  Psychol Addict Behav       Date:  2014-06

7.  One-year outcomes of a drug abuse prevention program for older teens and emerging adults: evaluating a motivational interviewing booster component.

Authors:  Steve Sussman; Ping Sun; Louise A Rohrbach; Donna Spruijt-Metz
Journal:  Health Psychol       Date:  2011-10-10       Impact factor: 4.267

Review 8.  Motivational interviewing to promote adherence behaviors in pediatric type 1 diabetes.

Authors:  Priscilla W Powell; Marisa E Hilliard; Barbara J Anderson
Journal:  Curr Diab Rep       Date:  2014-10       Impact factor: 4.810

9.  Influence of motivational interviewing on explicit and implicit alcohol-related cognition and alcohol use in at-risk adolescents.

Authors:  Carolien Thush; Reinout W Wiers; Mirjam Moerbeek; Susan L Ames; Jerry L Grenard; Steve Sussman; Alan W Stacy
Journal:  Psychol Addict Behav       Date:  2009-03

10.  Effect of motivational interviewing on reduction of alcohol use.

Authors:  Adeline Nyamathi; Steven Shoptaw; Allan Cohen; Barbara Greengold; Kamala Nyamathi; Mary Marfisee; Viviane de Castro; Farinaz Khalilifard; Daniel George; Barbara Leake
Journal:  Drug Alcohol Depend       Date:  2010-02-01       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.